Suppr超能文献

突破性菌血症的临床特征:392例病例的调查

Clinical characterization of breakthrough bacteraemia: a survey of 392 episodes.

作者信息

López Dupla M, Martinez J A, Vidal F, Almela M, López J, Marco F, Soriano A, Richart C, Mensa J

机构信息

Servei de Medicina Interna, Hospital Universitari Joan XXIII, Universitat Rovira i Virgili, Tarragona, Spain.

出版信息

J Intern Med. 2005 Aug;258(2):172-80. doi: 10.1111/j.1365-2796.2005.01513.x.

Abstract

BACKGROUND

Few data are available on the clinical features of patients who develop breakthrough bacteraemia, understood as positive blood cultures despite appropriate antibiotic therapy.

OBJECTIVES

To determine the clinical significance and outcome of a large series of breakthrough bacteraemia.

DESIGN

Retrospective analysis of a prospectively collected database.

SETTING

Two university-affiliated hospitals in Catalonia, Spain.

SUBJECTS

A total of 392 individuals who suffered an episode of breakthrough bacteraemia recorded between 1997 and 2002.

INTERVENTIONS

Demographic characteristics, underlying diseases, origin of infection, sources of infection, microorganisms isolated, McCabe and Jackson prognostic criteria, and mortality were analysed.

RESULTS

Breakthrough bacteraemia was detected in 392 of 6324 (6.1%) episodes of bacteraemia. Eighty per cent of episodes were nosocomial. The most frequent source of infection in breakthrough bacteraemia was endovascular (70%). Coagulase-negative staphylococci, Staphylococcus aureus, and Pseudomonas aeruginosa were the most significant microorganisms involved. Nosocomial acquisition together with selected sources (central venous catheter, endocarditis and other endovascular foci), underlying conditions (neutropenia, polytraumatism, allogenic bone marrow and kidney transplantation), and particular microbial aetiologies (S. aureus, P. aeruginosa and polymicrobial) were independently associated with increased risk for developing breakthrough bacteraemia. Crude mortality rate was greater in patients with breakthrough bacteraemia (16% vs. 12.3%; P<0.05), and this condition was an independent predictor of death (OR 1.4, 95% CI, 1-1.9; P=0.04).

CONCLUSIONS

In view of a case of breakthrough bacteraemia it is mandatory to search for an endovascular focus. Empiric treatment should be directed to cover S. aureus, coagulase-negative staphylococci and nonfermentative Gram-negative bacilli. Breakthrough bacteraemia is an independent predictor of death.

摘要

背景

关于发生突破性菌血症(即在接受适当抗生素治疗的情况下血培养仍呈阳性)患者的临床特征,目前可用的数据较少。

目的

确定大量突破性菌血症病例的临床意义和转归。

设计

对前瞻性收集的数据库进行回顾性分析。

地点

西班牙加泰罗尼亚的两家大学附属医院。

研究对象

1997年至2002年间记录的共392例发生突破性菌血症的个体。

干预措施

分析人口统计学特征、基础疾病、感染源、感染部位、分离出的微生物、麦凯布和杰克逊预后标准以及死亡率。

结果

在6324例菌血症病例中,有392例(6.1%)检测到突破性菌血症。80%的病例为医院获得性感染。突破性菌血症最常见的感染部位是血管内(70%)。凝固酶阴性葡萄球菌、金黄色葡萄球菌和铜绿假单胞菌是最主要的相关微生物。医院获得性感染以及特定的感染部位(中心静脉导管、心内膜炎和其他血管内病灶)、基础疾病(中性粒细胞减少、多发伤、同种异体骨髓和肾移植)以及特定的微生物病因(金黄色葡萄球菌、铜绿假单胞菌和多微生物感染)与发生突破性菌血症的风险增加独立相关。突破性菌血症患者的粗死亡率更高(16%对12.3%;P<0.05),并且这种情况是死亡的独立预测因素(比值比1.4,95%可信区间,1 - 1.9;P = 0.04)。

结论

鉴于突破性菌血症病例,必须寻找血管内病灶。经验性治疗应针对覆盖金黄色葡萄球菌、凝固酶阴性葡萄球菌和非发酵革兰阴性杆菌。突破性菌血症是死亡的独立预测因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验